Baricitinib plus dexamethasone compared to dexamethasone for the treatment of severe COVID-19 pneumonia: A retrospective analysis-Reference-Cited by-同舟云学术

Baricitinib plus dexamethasone compared to dexamethasone for the treatment of severe COVID-19 pneumonia: A retrospective analysis

Published:2021-10 Issue:5 Volume:54 Page:787-793
ISSN:1684-1182
Container-title:Journal of Microbiology, Immunology and Infection
language:en
Short-container-title:Journal of Microbiology, Immunology and Infection

Author:

Pérez-Alba Eduardo,Nuzzolo-Shihadeh Laura,Aguirre-García Gloria Mayela,Espinosa-Mora Jaime,Lecona-Garcia Juan Diego,Flores-Pérez Romulo Omar,Mendoza-Garza Marisela,Camacho-Ortiz Adrián

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Immunology and Microbiology,General Medicine,Immunology and Allergy

Reference22 articles.

1. Dexamethasone in hospitalized patients with Covid-19 - preliminary report;Horby;N Engl J Med,2020

2. A trial of lopinavir–ritonavir in adults hospitalized with severe Covid-19;Cao;N Engl J Med,2020

3. A randomized trial of convalescent plasma in Covid-19 severe pneumonia;Simonovich;N Engl J Med,2021

4. Effect of hydroxychloroquine in hospitalized patients with Covid-19;Horby;N Engl J Med,2020

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of baricitinib in patients with severe COVID-19: A systematic review and meta-analysis;Medicine;2023-12-01

2. The therapeutic effects of mesenchymal stem cell (MSCs) exosomes in covid-19 disease; Focusing on dexamethasone therapy;Pathology - Research and Practice;2023-11

3. Key patient demographics shape innate immune topography in noncritical hypoxic COVID-19 pneumonia;JCI Insight;2023-08-22

4. Use of Multiple Doses of Intravenous Infusion of Umbilical Cord-Mesenchymal Stem Cells for the Treatment of Adult Patients with Severe COVID-19-Related Acute Respiratory Distress Syndrome: Literature Review;Stem Cells International;2023-08-18

5. Propensity-Score Matched Analysis of the Effectiveness of Baricitinib in Patients With Coronavirus Disease 2019 (COVID-19) Using Nationwide Real-World Data: An Observational Matched Cohort Study From the Japan COVID-19 Task Force;Open Forum Infectious Diseases;2023-06-08